MMP inhibitors (Roche)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMMP inhibitors (Roche)
Drug Alias NameRo-206-0222
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 8 inhibitorsMatrix metalloproteinase-2 inhibitorsMatrix metalloproteinase 9 inhibitors
TargetsMatrix metalloproteinase 9Matrix metalloproteinase 8Matrix metalloproteinase-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoffmann-La Roche Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoffmann-La Roche Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A